{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:12:01Z","timestamp":1761718321906},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.2146\/ajhp130636","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T20:19:33Z","timestamp":1405455573000},"page":"1282-1287","source":"Crossref","is-referenced-by-count":11,"title":["Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults"],"prefix":"10.1093","volume":"71","author":[{"given":"Katie T.","family":"Blissit","sequence":"first","affiliation":[{"name":"William Jennings Bryan Dorn Veterans Affairs Medical Center, Columbia, SC."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Tillery","sequence":"additional","affiliation":[{"name":"School of Pharmacy, South University, Columbia."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Latham","sequence":"additional","affiliation":[{"name":"G. Werber Bryan Psychiatric Hospital, Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Pacheco-Perez","sequence":"additional","affiliation":[{"name":"G. Werber Bryan Psychiatric Hospital, Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"2019041211094643800_b1-0711282","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am J Psychiatry"},{"key":"2019041211094643800_b2-0711282","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: a clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"2019041211094643800_b3-0711282","volume-title":"Clozaril (clozapine) package insert","year":"2013"},{"key":"2019041211094643800_b4-0711282","first-page":"2628","article-title":"Sialorrhea: a management challenge","volume":"69","author":"Hockstein","year":"2004","journal-title":"Am Fam Physician"},{"key":"2019041211094643800_b5-0711282","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1358\/dot.2005.41.6.893628","article-title":"Drug-induced sialorrhea","volume":"41","author":"Freudenreich","year":"2005","journal-title":"Drugs Today"},{"key":"2019041211094643800_b6-0711282","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1345\/aph.1P761","article-title":"Current treatment strategies for clozapine-induced sialorrhea","volume":"45","author":"Bird","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2019041211094643800_b7-0711282","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0922-4106(94)90047-7","article-title":"Clozapine is a potent and selective muscarinic M4 receptor agonist","volume":"260","author":"Zorn","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"2019041211094643800_b8-0711282","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000296852","article-title":"Do central antiadrenergic actions contribute to the atypical properties of clozapine?","author":"Baldessarini","year":"1992","journal-title":"Br J Psychiatry Suppl"},{"key":"2019041211094643800_b9-0711282","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00023210-199504050-00006","article-title":"Clozapine: a review of its pharmacological properties and a therapeutic use in patients with schizophrenia who are unresponsive to or intolerant of classical antipsychotic agents","volume":"1","author":"Wagstaff","year":"1995","journal-title":"CNS Drugs"},{"issue":"suppl 2","key":"2019041211094643800_b10-0711282","first-page":"20","article-title":"Managing anticholinergic side effects","volume":"6","author":"Lieberman","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"2019041211094643800_b11-0711282","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/bjaceaccp\/mkh045","article-title":"Anticholinesterases and anticholinergic drugs","volume":"4","author":"Nair","year":"2004","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"2019041211094643800_b12-0711282","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1345\/aph.1Q270","article-title":"Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea","volume":"45","author":"Leung","year":"2011","journal-title":"Ann Pharmacother"},{"key":"2019041211094643800_b13-0711282","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/appi.ps.55.3.318","article-title":"Scopolamine patch for clozapine-induced sialorrhea","volume":"55","author":"Gaftanyuk","year":"2004","journal-title":"Psychiatr Serv"},{"key":"2019041211094643800_b14-0711282","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4103\/0019-5359.57642","article-title":"Trihexyphenidyl (benzhexol) in clozapine-induced nocturnal enuresis and sialorrhea","volume":"63","author":"Aggarwal","year":"2009","journal-title":"Indian J Med Sci"},{"key":"2019041211094643800_b15-0711282","first-page":"73","article-title":"Complete resolution of clozapine-induced sialorrhea with low dose trihexyphenidyl","volume":"43","author":"Praharaj","year":"2010","journal-title":"Psychopharmacol Bull"},{"key":"2019041211094643800_b16-0711282","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.pnpbp.2009.09.014","article-title":"Clozapine-induced sialorrhea alleviated by bupropion\u2014a case report","volume":"33","author":"Stern","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2019041211094643800_b17-0711282","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/0269881105053311","article-title":"Is clonidine useful for treatment of clozapine-induced sialorrhea?","volume":"19","author":"Praharaj","year":"2005","journal-title":"J Psychopharmacol"},{"key":"2019041211094643800_b18-0711282","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4088\/JCP.08m04495","article-title":"Treatment of clozapine-induced hypersalivation with ipratropium bromide: a randomized, double-blind, placebo-controlled crossover study","volume":"70","author":"Sockalingham","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"2019041211094643800_b19-0711282","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00213-009-1689-y","article-title":"Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea","volume":"207","author":"Steinlechner","year":"2010","journal-title":"Psychopharmacology"},{"key":"2019041211094643800_b20-0711282","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2010.02.1060","article-title":"Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study","volume":"119","author":"Liang","year":"2010","journal-title":"Schizophr Res"},{"key":"2019041211094643800_b21-0711282","volume-title":"Myobloc (rimabotulinumtoxinB) package insert","year":"2010"},{"key":"2019041211094643800_b22-0711282","article-title":"Glycopyrrolate (glycopyrronium): drug information","volume-title":"UpToDate","author":"Rose","year":"2013"},{"key":"2019041211094643800_b23-0711282","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.pnpbp.2007.06.013","article-title":"Glycopyrrolate for clozapine-induced sialorrhea","volume":"31","author":"Duggal","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2019041211094643800_b24-0711282","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/cap.2007.0037","article-title":"Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents","volume":"18","author":"Robb","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"2019041211094643800_b25-0711282","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","author":"Thomas-Stonell","year":"1988","journal-title":"Dysphagia"},{"key":"2019041211094643800_b26-0711282","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/71\/15\/1282\/28373058\/ajhp1282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,13]],"date-time":"2019-04-13T00:51:47Z","timestamp":1555116707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/71\/15\/1282\/5110892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":26,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp130636","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,8,1]]},"published":{"date-parts":[[2014,8,1]]}}}